Karen Tuzman, PHD

As Head of Discovery and Preclinical Research, Karen guides BioCentury’s coverage of emerging biology and technologies. She has written extensively about immunology, synthetic biology, diagnostics and data science, covering innovative breakthroughs in industry and academia, and dissecting trends in company formation and investments around new science. She coordinates activities and interactions with BioCentury’s Scientific Advisory Board.
Karen joined BioCentury in 2015 after a postdoctoral research fellowship in Stanford University's Department of Chemical and Systems Biology. She holds a Ph.D. in Immunology from Weill Cornell Medicine and a B.A. in Molecular and Cell Biology from the University of California Berkeley.